Stocktwits on MSN
Sellas Life Sciences draws significant retail buzz as traders eye REGAL phase 3 catalyst – SLS stock soars 15%
Sellas’ CEO referenced the company’s Phase 3 REGAL trial in a LinkedIn post, following its December update that the final analysis was approaching for GPS as a therapy in AML. ・Anson Funds Management ...
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In ...
$SLS insiders have traded $SLS stock on the open market 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales. Here’s a ...
SELLAS Life Sciences Group Inc. Times Square Tower 7 Times Square Suite 2503 New York, New York 10026 Phone1 646 200-5278 IndustryBiotechnology SectorHealth Care/Life Sciences Fiscal Year-end12/2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results